Our collaborators

Dr. Valerio Izzi - University of Oulu, Finland

Project: Development of computational tools to advance ECM research.

Git: https://github.com/Izzilab 

Dr. Yu (Tom) Gao - Department of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, IL, U.S.A

NIH-funded Project: Thinking outside the cell: Leveraging HuBMAP data to build the human ECM atlas (1U01HG012680-01)

NCI-funded Project: Enhanced mass-spectrometry-based approaches for in-depth profiling of the cancer extracellular matrix (1R21CA261642-01)

Dr. Sylvie Ricard-Blum - ICBMS, University Lyon 1, France.

Project: Characterization of the biophysical properties of SNED1 and defining the SNED1 interactome.

Dr. Pamela Kreeger - Department of Biomedical Engineering, University of Wisconsin, Madison, Madison, WI, U.S.A

NCI-funded Project: Engineered ECM platforms to analyze progression in high grade serous ovarian cancer (HGSOC).

Read more about our project here.

Dr. John Varga - Division of Rheumatology, University of Michigan Medical School, Ann Arbor, MI, U.S.A

Dr. Maria Teves  - Department of Obstetrics and Gynecology, Virginia Commonwealth University, Richmond, VA, U.S.A

NIH/NIAMS-funded Project: Damage-associated molecular patterns driving fibrosis progression in scleroderma.

Dr. Brian Rubin - Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, U.S.A.

Dr. John Lamar  - Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY, U.S.A

Project funded by a DoD Rare Cancer IDEA Award: Profiling of the ECM of human and murine epithelioid hemangioendothelioma (EHE) using proteomics.